Incyte
Venture capital · Wilmington, Delaware, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
2Deep-tech portfolio0 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Syndax Pharmaceuticals
8Co-investorsShare a portfolio company
Portfolio · 2 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Syndax Pharmaceuticals | Biotech | Public | Aug 28, 2015 | $139.5M |
| Merus | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#189
Portfolio exits#103
Raises, 12 months#88
Co-investors#173
Co-investors
- Atlas VentureVenture capital1 shared
- Domain AssociatesVenture capital1 shared
- Eli LillyVenture capital1 shared
- Foresite CapitalVenture capital1 shared
- Lilly VenturesVenture capital1 shared
- MedicxiVenture capital1 shared
- OrbiMedVenture capital1 shared
- RA CapitalVenture capital1 shared
Sectors
- Biotech2
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.